Anticancer drug carriers. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Liver HT29 Cells HCT116 Cells Mitochondria HeLa Cells Hep G2 Cells HL-60 Cells K562 Cells Cell Line KB Cells

Organisms5

Mice, Nude Mice, Inbred BALB C Taxus Rats, Wistar Mice, SCID

Diseases10

Neoplasms Breast Neoplasms Colonic Neoplasms Leukemia P388 Neoplasms, Experimental Lung Neoplasms Ovarian Neoplasms Leukemia L1210 Adenocarcinoma Prostatic Neoplasms

Chemicals and Drugs120

Drug Carriers Antineoplastic Agents Doxorubicin Nanocapsules Liposomes Chitosan Polyethylene Glycols Antibiotics, Antineoplastic Polymers Dendrimers Aconitic Acid Cellulose, Oxidized Micelles Polyglactin 910 Delayed-Action Preparations Poloxamer Emulsions Antineoplastic Agents, Phytogenic Polyesters Carrier Proteins Cisplatin Polyglycolic Acid Capsules Acrylamides Ellipticines Poly I Acyl Carrier Protein Surface-Active Agents Camptothecin P-Glycoprotein Etoposide Powders Paclitaxel Excipients Biocompatible Materials Reduced Folate Carrier Protein DNA Topoisomerases, Type II Prodrugs Serum Albumin Pharmaceutical Preparations Daunorubicin Lactic Acid Topoisomerase I Inhibitors Silicon Dioxide Enzyme Inhibitors Peptides Serum Albumin, Bovine Platinum Plant Extracts Organoplatinum Compounds Caspases Antimetabolites, Antineoplastic DNA Mitomycin Fluorouracil Multidrug Resistance-Associated Proteins Mitoxantrone Drugs, Investigational Intercalating Agents Neoplasm Proteins ATP-Binding Cassette Transporters DNA Adducts Caspase 3 Proto-Oncogene Proteins c-bcl-2 Lipids Xanthones Topoisomerase Inhibitors Adjuvants, Pharmaceutic Topoisomerase II Inhibitors Tumor Suppressor Protein p53 Tubulin Modulators Coordination Complexes DNA Topoisomerases, Type I Antineoplastic Agents, Alkylating Anticarcinogenic Agents Razoxane RNA, Small Interfering Vinblastine RNA, Messenger Teniposide Bleomycin Triazines Vinca Alkaloids Histone Deacetylase Inhibitors Triterpenes Pyrazines Topotecan Reactive Oxygen Species Membrane Transport Proteins Depsipeptides Benzoquinones Chlorambucil Boronic Acids Methotrexate Naphthoquinones Angiogenesis Inhibitors Amsacrine Rhodamine 123 DNA-Binding Proteins DNA, Neoplasm Nimustine Protein Kinase Inhibitors Taxoids Piperazines Proteasome Inhibitors Floxuridine Cross-Linking Reagents Indoles Vincristine Thiazoles Poly(ADP-ribose) Polymerases Anthracyclines Curcumin Aziridines Platinum Compounds Dioxoles Radiation-Sensitizing Agents Hydroxamic Acids Glutathione Caspase 9

Analytical, Diagnostic and Therapeutic Techniques and Equipment49

Drug Carriers Drug Delivery Systems Nanocapsules Drug Screening Assays, Antitumor Drug Compounding Technology, Pharmaceutical Fractionation, Field Flow Dendrimers Delayed-Action Preparations Calorimetry, Differential Scanning Microspheres Xenograft Model Antitumor Assays Powder Diffraction Drug Stability Heterozygote Detection Inhibitory Concentration 50 Drug Design Microbubbles Microscopy, Confocal Drug Evaluation, Preclinical Administration, Oral Microscopy, Electron, Scanning Drug Discovery Microscopy, Electron, Transmission Materials Testing Spectroscopy, Fourier Transform Infrared Microscopy, Fluorescence Injections, Intravenous Molecular Targeted Therapy Administration, Cutaneous Neoplasms, Experimental Neoplasm Transplantation Blotting, Western Flow Cytometry Models, Biological Models, Molecular Clinical Trials, Phase I as Topic Transfection Transplantation, Heterologous Antineoplastic Combined Chemotherapy Protocols Phytotherapy Clinical Trials as Topic Drug Approval Tumor Burden Tumor Stem Cell Assay Electrochemotherapy Reverse Transcriptase Polymerase Chain Reaction Chromatography, High Pressure Liquid Genetic Testing

Phenomena and Processes51

Particle Size Cell Survival Drug Resistance, Neoplasm Tissue Distribution Apoptosis Solubility Molecular Structure Dose-Response Relationship, Drug Surface Properties Cell Proliferation Drug Resistance, Multiple Inhibitory Concentration 50 Biological Availability Heterozygote Drug Synergism Hydrogen-Ion Concentration Kinetics DNA Damage Cell Cycle Time Factors Mutation Gene Expression Regulation, Neoplastic Endocytosis Structure-Activity Relationship DNA Adducts Drug Resistance Genes, MDR Signal Transduction Cell Division Cell Death Biological Transport Temperature Base Sequence Transfection Cell Cycle Checkpoints Down-Regulation DNA Repair Polymorphism, Genetic Protein Binding Genotype Amino Acid Sequence Drug Interactions G-Quadruplexes Genes, BRCA1 Enzyme Activation Phosphorylation Binding Sites DNA Fragmentation G2 Phase Phenotype Membrane Potential, Mitochondrial

Disciplines and Occupations8

Nanomedicine Chemistry, Pharmaceutical Technology, Pharmaceutical Nanotechnology Drug Design Magnetics Drug Discovery Pharmacogenetics

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval National Cancer Institute (U.S.)

Technology, Industry, Agriculture16

Nanoparticles Nanocapsules Liposomes Nanomedicine Polyethylene Glycols Polymers Technology, Pharmaceutical Dendrimers Nanostructures Polyglactin 910 Poloxamer Nanotechnology Polyesters Polyglycolic Acid Metal Nanoparticles Biocompatible Materials

Information Science3

Molecular Sequence Data Base Sequence Amino Acid Sequence

Health Care6

Carrier State Temperature Clinical Trials, Phase I as Topic Clinical Trials as Topic National Cancer Institute (U.S.)Genetic Testing

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Drug Carriers Drug Delivery Systems Antineoplastic Agents Nanoparticles Particle Size Cell Line, Tumor Doxorubicin Nanocapsules Liposomes Nanomedicine Drug Screening Assays, Antitumor Neoplasms Chemistry, Pharmaceutical Chitosan Polyethylene Glycols Antibiotics, Antineoplastic Drug Compounding Carrier State Polymers Technology, Pharmaceutical Fractionation, Field Flow Dendrimers Aconitic Acid Cell Survival Cellulose, Oxidized Micelles Nanostructures Polyglactin 910 Delayed-Action Preparations Drug Resistance, Neoplasm Poloxamer Nanotechnology Emulsions Tissue Distribution Apoptosis Antineoplastic Agents, Phytogenic Polyesters Mice, Nude Solubility Molecular Structure Carrier Proteins Cisplatin Polyglycolic Acid Capsules Tumor Cells, Cultured Acrylamides Ellipticines Dose-Response Relationship, Drug Calorimetry, Differential Scanning Microspheres Xenograft Model Antitumor Assays Poly I Powder Diffraction Acyl Carrier Protein Drug Stability Surface-Active Agents Surface Properties Cell Proliferation Metal Nanoparticles Heterozygote Detection Camptothecin Drug Resistance, Multiple P-Glycoprotein Inhibitory Concentration 50 Etoposide Powders Paclitaxel Drug Design Excipients Biocompatible Materials Biological Availability Magnetics Mice, Inbred BALB C Heterozygote Drug Synergism Hydrogen-Ion Concentration Reduced Folate Carrier Protein Microbubbles DNA Topoisomerases, Type II Prodrugs Serum Albumin Pharmaceutical Preparations Kinetics Breast Neoplasms Daunorubicin Lactic Acid Topoisomerase I Inhibitors Silicon Dioxide DNA Damage Enzyme Inhibitors Peptides Cell Cycle Serum Albumin, Bovine Platinum Microscopy, Confocal Drug Evaluation, Preclinical Administration, Oral Time Factors Microscopy, Electron, Scanning Plant Extracts

No FAQ available that match "anticancer drug carriers"